Showing results (131-140 of 71,127) with videos related to
Sort By:
Pageof 7,113
Kidney International|June 1, 1986
Guanabenz: a centrally acting, natriuretic antihypertensive drugM Gehr, E P MacCarthy, M GoldbergCurrent Opinion in Nephrology and Hypertension|February 18, 2003
Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerationsDomenic A Sica, Todd W B GehrHNO|December 4, 2003
[Automated hearing threshold estimation in newborns using extrapolated DPOAE input/output functions]T Janssen, A Klein, D D GehrAmerican Journal of Respiratory Cell and Molecular Biology|February 3, 2007
Dendritic cells and macrophages form a transepithelial network against foreign particulate antigensFabian Blank, Barbara Rothen-Rutishauser, Peter GehrBMC Medical Research Methodology|May 13, 2006
The fading of reported effectiveness. A meta-analysis of randomised controlled trialsBernhard T Gehr, Christel Weiss, Franz PorzsoltJournal of Cell Science|August 1, 1988
Diacylglycerol-induced shape changes, movements and altered F-actin distribution in human neutrophilsA Zimmermann, P Gehr, H U KellerJournal of Morphology|April 1, 1981
Allometric analysis of the morphometric pulmonary diffusing capacity in dogsP Gehr, B Siegwart, E R WeibelThe American Journal of Geriatric Cardiology|January 5, 2002
Rhabdomyolysis and statin therapy: relevance to the elderlyDomenic A Sica, Todd W B GehrJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 14, 2003
The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal diseaseDomenic A Sica, Todd W B GehrInfection and Drug Resistance|September 28, 2020
No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical TrialsKamal Hamed, Tatiana Wiktorowicz, Maziar Assadi GehrPageof 7,113